CLSI I/LA21 A : 1ED 2002

Gives recommendations on designing trials that are appropriate for evaluating both the safety and effectiveness of immunoassays. It will be a valuable resource in determining the necessary steps in designing an evaluation for new methods, new applications for existing methods, or variations on existing methods.